- Home
- FUSB vs ICCC Comparison
FUSB vs ICCC Comparison
Compare FUSB & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- ICCC
- Stock Information
- Founded
- FUSB 1952
- ICCC 1982
- Country
- FUSB United States
- ICCC United States
- Employees
- FUSB N/A
- ICCC N/A
- Industry
- FUSB Major Banks
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- FUSB Finance
- ICCC Health Care
- Exchange
- FUSB Nasdaq
- ICCC Nasdaq
- Market Cap
- FUSB 69.3M
- ICCC 60.1M
- IPO Year
- FUSB N/A
- ICCC 1987
- Fundamental
- Price
- FUSB $12.22
- ICCC $5.90
- Analyst Decision
- FUSB
- ICCC
- Analyst Count
- FUSB 0
- ICCC 0
- Target Price
- FUSB N/A
- ICCC N/A
- AVG Volume (30 Days)
- FUSB 4.2K
- ICCC 7.3K
- Earning Date
- FUSB 10-23-2025
- ICCC 11-12-2025
- Dividend Yield
- FUSB 2.20%
- ICCC N/A
- EPS Growth
- FUSB N/A
- ICCC N/A
- EPS
- FUSB 0.97
- ICCC 0.20
- Revenue
- FUSB $36,046,000.00
- ICCC $28,274,756.00
- Revenue This Year
- FUSB N/A
- ICCC N/A
- Revenue Next Year
- FUSB N/A
- ICCC N/A
- P/E Ratio
- FUSB $12.50
- ICCC $29.65
- Revenue Growth
- FUSB N/A
- ICCC 21.75
- 52 Week Low
- FUSB $10.30
- ICCC $3.34
- 52 Week High
- FUSB $14.30
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- FUSB 52.37
- ICCC 41.49
- Support Level
- FUSB $11.59
- ICCC $6.29
- Resistance Level
- FUSB $12.22
- ICCC $6.42
- Average True Range (ATR)
- FUSB 0.62
- ICCC 0.27
- MACD
- FUSB 0.10
- ICCC -0.04
- Stochastic Oscillator
- FUSB 51.94
- ICCC 21.98
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.